February 13, 2025 - 20:05

In a surprising move, Senator Mitch McConnell, a polio survivor himself, stood alone among Republicans by voting against the nomination of Robert F. Kennedy Jr. for the position of Health Secretary. McConnell's decision has sparked discussions about the implications of Kennedy's controversial views on vaccines and public health.
During a recent Senate session, McConnell articulated his concerns, emphasizing the need for a health secretary who prioritizes scientific integrity and public trust. He expressed that Kennedy's history of promoting vaccine skepticism could undermine the critical efforts needed to address public health challenges, especially in a post-pandemic world.
McConnell's vote reflects a broader concern among some lawmakers regarding the potential impact of Kennedy's leadership on health policy. As the Senate continues to navigate complex health issues, McConnell's dissent highlights the importance of aligning health leadership with established scientific consensus and the need for unity in addressing public health crises.
May 13, 2026 - 19:53
From Zambia to Harvard: How Chimba Sanga Is Fighting HIV and TB With New SkillsChimba Sanga, a physician and public health leader from Zambia, is bringing his Harvard training back home to tackle two of the country`s deadliest diseases. Sanga, currently a Master of Public...
May 13, 2026 - 01:07
AP report: Marty Makary resigning as Trump's FDA chiefMarty Makary is resigning as head of the Food and Drug Administration, according to an Associated Press report. His departure comes after a turbulent tenure marked by deep internal discord and a...
May 12, 2026 - 10:26
Shortage of beds, staff force Michigan kids out of state for mental health treatmentMichigan children facing severe mental health crises are increasingly being transported out of state for treatment, sometimes traveling thousands of miles away from their families. The root cause...
May 11, 2026 - 17:47
Medicare’s miss on Alzheimer’s drug spendingFar fewer seniors than expected are taking costly Alzheimer`s drugs, leaving Medicare spending well below earlier government forecasts. The new class of amyloid-targeting treatments, including...